THE human pituitary hormones, growth hormone (hGH) and prolactin (hPRL
), regulate a large variety of physiological processes, among which ar
e growth and differentiation of muscle, bone and cartilage cells, and
lactation(1). These activities are initiated by hormone-receptor bindi
ng. The hGH and hPRL receptors (hGH(R) and hPRL(R), respectively) are
single-pass transmembrane receptors from class 1 of the haematopoietic
receptor superfamily(2,3). This classification is based on sequence s
imilarity in their extracellular domains, notably a highly conserved p
entapeptide, the so-called 'WSXWS box', the function of which is contr
oversial. All ligands in class 1 activate their respective receptors b
y clustering mechanisms(4). In the case of hGH, activation involves re
ceptor homodimerization in a sequential process: the active ternary co
mplex containing one ligand and two receptor molecules is formed by as
sociation of a receptor molecule to an intermediate 1:1 complex(5-8).
hPRL does not bind to the hGH receptor, but hGH binds to both the hGH(
R) and hPRL(R), and mutagenesis studies have shown that the receptor-b
inding sites on hGH overlap(9). We present here the crystal structure
of the 1:1 complex of hGH bound to the extracellular domain of the hPR
L(R). Comparisons with the hGH-hGH(R) complex(10) reveal how hGH can b
ind to the two distinctly different receptor binding surfaces.